LIVE FROM THE DATABASETRANSACTIONS 362,430COMPANIES 5,763LATEST TRADE Oct 16UPDATED Oct 17, 12:31 AM
IKTCIK 0001750149

Inhibikase Therapeutics, Inc.

16 transactions by 10 insiders, from January 5, 2026 to July 30, 2026.

Transactions
1610 insiders
Bought · P
Nonenobody bought on the open market
Sold · S
Nonenobody sold on the open market
Net
+$0net buying

Officers and directors

People inside the company. What they do with their own shares is the reason this data exists.

InsiderTradesPlannedBoughtSold
Dennis N. BermanDir3———
Vincent AurentzDir2———
Amit MunshiDir2———
Christopher CabellPres2———
David McIntyreCFO1———
Roberto BelliniDir1———
David CannerDir1———
Mark T. IwickiCEO1———
Arvind KushDir1———

Large holders and funds

Holders above 10%, often funds. They file the same form, but they trade for portfolio reasons, not because of what they know.

InsiderTradesPlannedBoughtSold
RA CAPITAL MANAGEMENT, L.P.10%2———

All transactions

16 in total, newest filings first.

InsiderDateCodeSharesPriceValue
RA CAPITAL MANAGEMENT, L.P.10%DERIVJOINTJul 29J18,030,000——
RA CAPITAL MANAGEMENT, L.P.10%JOINTJul 29J18,030,000——
Dennis N. BermanDirDERIVJul 30M21,854$0.00—?
Dennis N. BermanDirJul 30M21,854$1.26$28K
Arvind KushDirDERIVJun 26A155,000$0.00—?
Amit MunshiDirDERIVJun 26A155,000$0.00—?
David CannerDirDERIVJun 26A155,000$0.00—?
Roberto BelliniDirDERIVJun 26A155,000$0.00—?
Dennis N. BermanDirDERIVJun 26A155,000$0.00—?
Vincent AurentzDirDERIVJun 26A155,000$0.00—?
Amit MunshiDirFeb 21D19,089$0.00—
Christopher CabellPresFeb 21D338,282$0.00—
Vincent AurentzDirFeb 21D255,299$0.00—
Mark T. IwickiCEODERIVJan 5A4,982,706$0.00—?
David McIntyreCFODERIVJan 5A986,319$0.00—?
Christopher CabellPresDERIVJan 5A900,117$0.00—?